CTLA4 and hepatocellular carcinoma: Such immune phenotype of HCC TME probably links with checkpoint molecules CD27, CD40, CD28, and CTLA4, which leads to enriched inhibitory cells while depleting effector immune cells, although this hypothesis needs to be validated experimentally.